Status checked Oct 25, 2026, 12:37 AM · America/New_York
Observed Sep 21, 2026, 8:00 PM UTC · Last available price
The latest observed price above is market data. Forecast starting prices are issuance-frozen values and are labelled separately in Model Forecast below.
International Flavors & Fragrances Inc. (IFF) stock forecast and scoring
Review the dated model forecast and five-factor Scorecard for IFF. Each has its own availability and reference date; a score is a relative comparison, not a price prediction.
12M forecast summary
Target date · Sep 21, 2027
Lower Estimate (P10)
$56.38
-32.6%
Median Estimate (P50)
$90.93
+8.8% from starting price
Upper Estimate (P90)
$123.61
+47.9%
$56.38Median $90.93$123.61
Median Estimate
$90.93
Starting price
$83.60
Change from starting price
+8.8%
Target date
Sep 21, 2027
Data through
Sep 21, 2026
The estimate uses its dated starting price. It does not predict returns from today’s quote.
International Flavors & Fragrances Inc. (IFF), through its various subsidiaries, operates as a global developer and purveyor of active cosmetic and natural health ingredients. These vital components are incorporated into a wide array of consumer goods distributed across significant markets such as Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. The company's activities are organized into four principal divisions: 1. Nourish: This segment focuses on natural and plant-derived specialty food ingredients, offering items like flavor compounds, savory solutions, and inclusions. It also provides natural food protection solutions, including antioxidants and anti-microbials, for use in beverages, confectionery, and dairy items. 2. Scent: The Scent division creates fragrance compounds, encompassing luxurious fine fragrances (perfumes and colognes) and everyday consumer fragrances. It further supplies essential fragrance ingredients, both synthetic and natural, which are blended to formulate new scents. Additionally, this segment delivers cosmetic active ingredients, such as functional compounds, botanicals, and advanced delivery systems, designed to enhance customers' cosmetic and personal care product lines. 3. Health & Biosciences: This segment is dedicated to the research, development, and production of enzymes, food cultures, probiotics, and other specialized biological ingredients. 4. Pharma Solutions: This division is responsible for manufacturing and distributing cellulosic and seaweed-derived pharmaceutical excipients. IFF's diverse customer base primarily consists of manufacturers in sectors including perfumery, cosmetics, hair and personal care, soaps and detergents, cleaning products, dairy, meat and processed foods, beverages, snacks and savory items, sweet and baked goods, dietary supplements, infant and elderly nutrition, functional foods, and producers of pharmaceutical excipients and oral care products. Established in 1833, International Flavors & Fragrances Inc. is headquartered in New York, New York.
Similar Stocks
Research snapshot
Loading research…
Risk / safety methodology: Safety describes recent price swings and distance from a recent high alongside cash flow and profitability. It is not a credit rating or a promise of protection from loss.
Scoring · International Flavors & Fragrances Inc. (IFF) stock scorecard
Multi-factor scoring at a glance
Individual factor readings · Shading shows available dimensions only. Overall requires all five scores and a comparable peer group.
Sector · Sector averages available for 0 of 5 dimensions. Sector Avg.
How its valuation measures compare with the group.
Quality
Plus or Pro
How its profitability and operating quality compare.
Safety
61.9
0255075100
Strong
How its price swings, distance from a recent high, cash flow and profitability compare.
Momentum
71.2
0255075100
Strong
How its recent price-trend measures compare.
Company snapshotDescriptive peer comparisonScore date: Sep 22, 2026Historical snapshot
All scores in this Scorecard describe relative characteristics as of the shown date, using historical market data and reported company information; higher scores on the 0–100 scale indicate more favorable characteristics in the relevant comparison group, and none forecasts future performance.
Scores are relative comparisons, not absolute grades: companies with different coverage may be scored on different inputs. Peer positions and input coverage can differ by factor; use the displayed comparison group and date when comparing readings. An 80 is not an 80% chance of a price rise. These scores are not price forecasts or recommendations.
The rank with complete inputs compares only companies with every input for that factor, using the issued scores. Equal partial coverage percentages do not establish matching inputs. Current stockwide snapshots use matching input groups; older snapshots may use a smaller fixed group. Scores do not separately adjust for industry or company size. Growth readings do not establish multi-year persistence or separate share-count effects from EPS growth. Scores are independent of the selected forecast horizon.
Research snapshot
Latest update · 2026-09-21
View Plans to read the previous successful update.
Previous update means the last successfully published update, including across weekends and market holidays. The Analysis tab keeps the information used in its latest report.
Research starting points
Open a ready-made screen, review its filters and adapt it to your questions.
Start with profit, cash generation and financial flexibility. Scores describe relative characteristics and do not predict returns.
Revenue · trailing 12 months
$9.98B
2025-07-01 to 2026-06-30
Net income · trailing 12 months
$290M
2025-07-01 to 2026-06-30
Free cash flow · trailing 12 months
$536M
2025-07-01 to 2026-06-30
Consolidated debt
$6.24B
At 2026-06-30
Dates and reporting periods
Market observations, financial reporting periods and report dates can differ. Each measure shows its own period.
Research data through 2026-09-21
Update published 2026-09-22
Currency: USD
Company comparison
Compare company metrics only when their currency, observation date and reporting periods agree. Similar companies are starting points for research, not substitutes for each other.
12-month forecasts show model median estimates (P50), with changes from each forecast’s starting price. Headline scores describe dated company characteristics; they do not predict future performance.